These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 15351581)
1. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581 [TBL] [Abstract][Full Text] [Related]
2. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467 [TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579 [TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683 [TBL] [Abstract][Full Text] [Related]
5. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709 [TBL] [Abstract][Full Text] [Related]
6. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298 [TBL] [Abstract][Full Text] [Related]
7. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
8. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer. Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444 [TBL] [Abstract][Full Text] [Related]
9. Influence of radical prostatectomy on serum hormone levels. Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896 [TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in the treatment of prostate cancer. Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261 [TBL] [Abstract][Full Text] [Related]
11. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening. Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487 [TBL] [Abstract][Full Text] [Related]
12. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872 [TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730 [TBL] [Abstract][Full Text] [Related]
14. Lycopene and soy isoflavones in the treatment of prostate cancer. Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495 [TBL] [Abstract][Full Text] [Related]
15. Effects of one-year treatment with isoflavone extract from red clover on prostate, liver function, sexual function, and quality of life in men with elevated PSA levels and negative prostate biopsy findings. Engelhardt PF; Riedl CR Urology; 2008 Feb; 71(2):185-90; discussion 190. PubMed ID: 18308079 [TBL] [Abstract][Full Text] [Related]
16. The specific role of isoflavones in reducing prostate cancer risk. Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614 [TBL] [Abstract][Full Text] [Related]
17. Is there a role for serum human tissue kallikrein in detection of prostate cancer? Ochiai A; Shukla A; Davis JW; Fritsche HA; Bhadkamkar V; Babaian RJ Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108 [TBL] [Abstract][Full Text] [Related]
18. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals. Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Morgentaler A; Rhoden EL Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]